Method of treating depression, mood disorders and anxiety disorders using neuromodulation

• US 8,190,264 B2
• Filed: 01/12/2010
• Issued: 05/29/2012
• Est. Priority Date: 06/19/2003
• Status: Active Grant

• Current Assignee: Advanced Neuromodulation Systems Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Advanced Neuromodulation Systems Incorporated (Abbott Laboratories Incorporated)
• Inventors: Lozano, Andres M, Mayberg, Helen S
• Primary Examiner(s): MANUEL, GEORGE C
• Application Number:
  US12/686,030
• Publication Number:
  US 20100114193A1
• Time in Patent Office: 868 Days
• Field of Search: 607/45
• US Class Current: 607/45
• CPC Class Codes: A61B 5/4848 Monitoring or testing the effects of treatment, e.g. of medication
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: A61N 1/0534 Electrodes for deep brain stimulation
• CPC Class Codes: A61N 1/36096 Mood disorders, e.g. depression, anxiety or panic disorder
• CPC Class Codes: A61N 1/36185 Selection of the electrode configuration
• CPC Class Codes: A61P 25/00 Drugs for disorders of the nervous system
• CPC Class Codes: A61P 25/24 Antidepressants

Abstract

The present application involves a method and a system for using electrical stimulation and/or chemical stimulation to treat depression. More particularly, the method comprises surgically implanting an electrical stimulation lead and/or catheter that is in communication with a predetermined site which is coupled to a signal generator and/or infusion pump that release either an electrical signal and/or a pharmaceutical resulting in stimulation of the predetermined site thereby treating the mood and/or anxiety.

Claims

1. A method for the treatment of depression in a patient, the method comprising administration of electrical stimulation to gray and white matter inferior to the corpus callosum and posterior to the anterior most portion of the genu of the corpus callosum to decrease or substantially ameliorate the depression.

2. A method for treating a mood and/or anxiety disorder, the method comprising administration of electrical stimulation to neural tissue about 0 mm to 10 mm below the intra-commissural line, about 2 mm to 14 mm from midline and about 20 to about 40 mm anterior to the anterior commissure to decrease or substantially ameliorate the mood and/or anxiety disorder.

3. The method of claim 2 wherein the mood disorder is selected from a group consisting of major depressive disorder, bipolar disorder, and dysthymic disorder.

4. The method of claim 2 wherein the mood disorder is major depressive disorder.

5. The method of claim 2 wherein the anxiety disorder is selected from a group consisting of panic disorder, posttraumatic stress disorder, obsessive-compulsive disorder and phobic disorder.

6. The method of claim 2 wherein stimulation of the neural tissue modulates other targets in the limbic-cortical circuit.

7. A method for modulating limbic-cortical circuits to treat mood disorders or anxiety disorders, the method comprising administration of electrical stimulation to gray and white matter inferior to the rostrum and genu of the corpus callosum and about 20 to about 40 mm anterior to the anterior commissure.

8. The method of claim 7 further comprising administering chemical stimulation.

9. The method of claim 8 wherein the chemical stimulation comprises administration of excitatory neurotransmitter agonists.

10. The method of claim 8 wherein the chemical stimulation comprises administration of inhibitory neurotransmitter antagonists.